investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to RAF inhibitors
Andrew E Aplin
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Andrew E Aplin
Thomas Jefferson University
Philadelphia, United States
Related projects
Jennifer Q Zhang
Tyrosine kinase inhibition and immunomodulation for cancer
Melanoma of skin
Ian Lisle Linde
Mechanistic basis of allogeneic IgG-induced tumor eradication
Melanoma of skin
Colin B Begg
Statistical Strategies for Establishing Etiologic Heterogeneity of Tumors
Melanoma of skin
Zhimin Lu
Regulation of nuclear Beta-catenin in EGFR-promoted tumor development.
Melanoma of skin
Estela Jacinto
Cotranslational Functions of MTOR
Melanoma of skin
Pathology
Bruce Furie
Protein disulfide isomerases: A new class of antithrombotic targets
Melanoma of skin
Jennifer L Hay
Personalized Genomic Testing for Melanoma: Maximizing Personal Utility and Reach
Melanoma of skin
Anatoly Zhitkovich
Formaldehyde Genotoxicity
Melanoma of skin
Deborah Johnson
Novel targets that are deregulated by loss of PTEN
Melanoma of skin